stereotactic ablative radiotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for stereotactic ablative radiotherapy, covering 2024-03-27 to 2024-03-27. Get the full timeline:
Most recent: Clinical Trial Update: SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer [Phase 1, Phase 2]